Drug class
Central Adrenolytics
Central adrenolytics, also widely known as centrally acting sympatholytics, are a class of cardiovascular agents that suppress sympathetic nervous system activity originating within the central nervous system. Read more about Central Adrenolytics
94 drugs in this class 57 manufacturers
Drugs in Central Adrenolytics
METHYLDOPA-HYDROCHLOROTHIAZIDE (methyldopa/hydrochlorothiazide)
METHYLDOPA
INTUNIV (guanfacine HCl)
GUANFACINE HCL
METHYLDOPATE HCL
METHYLDOPA
CLONIDINE HCL
CLONIDINE HCL
Central adrenolytics, also widely known as centrally acting sympatholytics, are a class of cardiovascular agents that suppress sympathetic nervous system activity originating within the central nervous system.
These medications—most notably central alpha-2 adrenergic agonists such as clonidine, methyldopa, and guanfacine—stimulate presynaptic alpha-2 receptors or imidazoline receptors in the brainstem, thereby decreasing central sympathetic outflow, reducing peripheral vascular resistance, and lowering heart rate and blood pressure.
Their primary therapeutic role is in managing hypertension, including resistant hypertension and hypertensive disorders of pregnancy, and selected agents also find therapeutic utility in neuropsychiatric conditions such as attention-deficit/hyperactivity disorder.
-
scribd.com
Central adrenolytics, also widely known as centrally acting sympatholytics, are a class of cardiovascular agents that suppress sympathetic nervous system activity originating within the central nervous system These medications—most notably central alpha-2 adrenergic agonists such as clonidine, methyldopa, and guanfacine—stimulate presynaptic alpha-2 receptors or imidazoline receptors in the brainstem, thereby decreasing central sympathetic outflow, reducing peripheral vascular resistance, and lo...
-
cvpharmacology.com
Central adrenolytics, also widely known as centrally acting sympatholytics, are a class of cardiovascular agents that suppress sympathetic nervous system activity originating within the central nervous system These medications—most notably central alpha-2 adrenergic agonists such as clonidine, methyldopa, and guanfacine—stimulate presynaptic alpha-2 receptors or imidazoline receptors in the brainstem, thereby decreasing central sympathetic outflow, reducing peripheral vascular resistance, and lo...
-
connectrx.com
These medications—most notably central alpha-2 adrenergic agonists such as clonidine, methyldopa, and guanfacine—stimulate presynaptic alpha-2 receptors or imidazoline receptors in the brainstem, thereby decreasing central sympathetic outflow, reducing peripheral vascular resistance, and lowering heart rate and blood pressure
-
cvpharmacology.com
These medications—most notably central alpha-2 adrenergic agonists such as clonidine, methyldopa, and guanfacine—stimulate presynaptic alpha-2 receptors or imidazoline receptors in the brainstem, thereby decreasing central sympathetic outflow, reducing peripheral vascular resistance, and lowering heart rate and blood pressure
-
anthem.com
Their primary therapeutic role is in managing hypertension, including resistant hypertension and hypertensive disorders of pregnancy, and selected agents also find therapeutic utility in neuropsychiatric conditions such as attention-deficit/hyperactivity disorder
-
nih.gov
Their primary therapeutic role is in managing hypertension, including resistant hypertension and hypertensive disorders of pregnancy, and selected agents also find therapeutic utility in neuropsychiatric conditions such as attention-deficit/hyperactivity disorder
-
elsevierpure.com
Their primary therapeutic role is in managing hypertension, including resistant hypertension and hypertensive disorders of pregnancy, and selected agents also find therapeutic utility in neuropsychiatric conditions such as attention-deficit/hyperactivity disorder
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.